Kymera Therapeutics (NasdaqGM:KYMR) Q3 2025 Earnings Call November 04, 2025 08:30 AM ET Speaker3Good day, everyone. My name is Sophie, and I will be your conference operator today. At this time, I would like to welcome you to the Kymera Therapeutics third quarter 2025 results call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. If you would like to ask a question during this time, and you have joined via the webin ...

Kymera Therapeutics Third Quarter 2025 Quarterly Results Call November 4, 2025 Agenda Introduction Justine Koenigsberg, Vice President, Investor Relations Key Highlights and Business Update Nello Mainolfi, PhD, Founder, President and Chief Executive Officer Clinical Update Jared Gollob, MD, Chief Medical Officer Financial Review Bruce Jacobs, CFA, MBA, Chief Financial Officer Question and Answer Session Forward Looking Statements This presentation contains forward-looking statements within the meaning of th ...